Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 2
2009 1
2011 2
2012 2
2014 1
2018 1
2020 2
2021 1
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
High-throughput electron tomography identifies centriole over-elongation as an early event in plasma cell disorders.
Köhrer S, Dittrich T, Schorb M, Weinhold N, Haberbosch I, Börmel M, Pajor G, Goldschmidt H, Müller-Tidow C, Raab MS, John L, Seckinger A, Brobeil A, Dreger P, Tornóczky T, Pajor L, Hegenbart U, Schönland SO, Schwab Y, Krämer A. Köhrer S, et al. Among authors: pajor g. Leukemia. 2023 Dec;37(12):2468-2478. doi: 10.1038/s41375-023-02056-y. Epub 2023 Oct 11. Leukemia. 2023. PMID: 37821581 Free PMC article.
A high-throughput electron tomography workflow reveals over-elongated centrioles in relapsed/refractory multiple myeloma.
Dittrich T, Köhrer S, Schorb M, Haberbosch I, Börmel M, Goldschmidt H, Pajor G, Müller-Tidow C, Raab MS, Hegenbart U, Schönland SO, Schwab Y, Krämer A. Dittrich T, et al. Among authors: pajor g. Cell Rep Methods. 2022 Nov 1;2(11):100322. doi: 10.1016/j.crmeth.2022.100322. eCollection 2022 Nov 21. Cell Rep Methods. 2022. PMID: 36452870 Free PMC article.
Addition of Chromosome 17 Polysomy and HER2 Amplification Status Improves the Accuracy of Clinicopathological Factor-Based Progression Risk Stratification and Tumor Grading of Non-Muscle-Invasive Bladder Cancer.
Kocsmár I, Kocsmár É, Pajor G, Kulka J, Székely E, Kristiansen G, Schilling O, Nyirády P, Kiss A, Schaff Z, Riesz P, Lotz G. Kocsmár I, et al. Among authors: pajor g. Cancers (Basel). 2022 Sep 21;14(19):4570. doi: 10.3390/cancers14194570. Cancers (Basel). 2022. PMID: 36230493 Free PMC article.
Development and Initial Testing of a Modified UroVysion-Based Fluorescence In Situ Hybridization Score for Prediction of Progression in Bladder Cancer.
Kocsmár I, Pajor G, Gyöngyösi B, Székely E, Varga M, Kocsmár É, Kenessey I, Beöthe T, Süle N, Majoros A, Szendrői A, Nyírády P, Kiss A, Riesz P, Lotz G. Kocsmár I, et al. Among authors: pajor g. Am J Clin Pathol. 2020 Jan 2;153(2):274-284. doi: 10.1093/ajcp/aqz165. Am J Clin Pathol. 2020. PMID: 31732739
15 results